Eywa Pharma
Singapore, SG · 1 known investors
Eywa Pharma develops and manufactures generic drugs across multiple therapeutic areas and dosage forms, including tablets, capsules, and oral suspensions, for patients and pharmacies. It sells products under the Eywa label in the U.S. and the Zista name in the UK, with development in Chennai, India and manufacturing in Cranbury, New Jersey.
Founders & leadership
Board
KP
Ketan PatelBoard director
Investors · 1
Competitors · 2
by search overlap
Preqin4 shared keywordsPreqin provides private markets data, analytics, and benchmarking across private equity, venture capital, hedge funds, real estate, private credit, infrastructure, secondaries, and natural resources. Its products serve fund managers, investors, consultants, banks, and other financial professionals for fundraising, manager selection, due diligence, and performance analysis.
Eywa3 shared keywordsEywa produces clinical-grade psychedelic compounds — including psilocybin, DMT, 5-MeO-DMT, and bufotenine — as APIs and finished drug products made through biosynthesis for use in scientific research, clinical trials, and commercial mental health applications. It also offers a dual-platform app for therapists and patients to personalize and monitor mental health treatment.
Companies competing with Eywa Pharma for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Eywa Pharma do?
- Eywa Pharma develops and manufactures generic drugs across multiple therapeutic areas and dosage forms, including tablets, capsules, and oral suspensions, for patients and pharmacies. It sells products under the Eywa label in the U.S. and the Zista name in the UK, with development in Chennai, India and manufacturing in Cranbury, New Jersey.
- Who are Eywa Pharma's investors?
- Eywa Pharma's investors include F-Prime Capital.
- Where is Eywa Pharma headquartered?
- Eywa Pharma is headquartered in Singapore, SG.